Obesity and Comorbidity: Could Simultaneous Targeting of esRAGE and sRAGE Be the Panacea?

Obesity, a chronic multifaceted disease, predisposes its patients to increased risk of metabolic disorders such as: diabetes mellitus, cardiovascular diseases, dyslipidemia, etc. Recent studies reported it to be amongst the leading causes of deaths in the world. Although several treatment options fo...

Full description

Bibliographic Details
Published in:	Frontiers in Physiology
Main Authors:	Chinedum Eleazu, Norsuhana Omar, Oon Zhi Lim, Boon Seng Yeoh, Nik Hazlina Nik Hussain, Mahaneem Mohamed
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2019-06-01
Subjects:	obesity nutrition metabolic dysregulation receptor for advanced glycation end products metabolic syndrome
Online Access:	https://www.frontiersin.org/article/10.3389/fphys.2019.00787/full

Similar Items

Corrigendum: Obesity and Comorbidity: Could Simultaneous Targeting of esRAGE and sRAGE Be the Panacea?
by: Chinedum Eleazu, et al.
Published: (2019-08-01)

In Patients with Chronic Kidney Disease Advanced Glycation End-Products Receptors Isoforms (sRAGE and esRAGE) Are Associated with Malnutrition
by: Lara Caldiroli, et al.
Published: (2022-06-01)

Evaluation of the AGE/sRAGE Axis in Patients with Multiple Myeloma
by: Alessandro Allegra, et al.
Published: (2019-03-01)

Predictive value of ELWI combined with sRAGE/esRAGE levels in the prognosis of critically ill patients with acute respiratory distress syndrome
by: Chengliang Zhang, et al.
Published: (2023-09-01)

Polymorphisms −374 T/A and −429 T/C of the Receptor for Advanced Glycation End-Products (RAGE) and Serum Levels of RAGE (sRAGE) Are Not Associated with Metabolic Syndrome
by: Diana Elizabeth González-Guerrero, et al.
Published: (2023-04-01)

The impact of polytrauma on sRAGE levels: evidence and statistical analysis of temporal variations
by: Lukas L. Negrin, et al.
Published: (2019-03-01)

The Assessment of Serum Concentrations of AGEs and Their Soluble Receptor (sRAGE) in Multiple Sclerosis Patients
by: Aleksandra Damasiewicz-Bodzek, et al.
Published: (2021-07-01)

High BAL sRAGE is Associated with Low Serum Eosinophils and IgE in Children with Asthma
by: Jason T. Patregnani, et al.
Published: (2020-08-01)

esRAGE-expressing oHSV enhances anti-tumor efficacy by inhibition of endothelial cell activation
by: Jessica Swanner, et al.
Published: (2023-03-01)

Evaluation of circulating sRAGE in osteoporosis according to BMI, adipokines and fracture risk: a pilot observational study
by: Emanuela Galliera, et al.
Published: (2017-06-01)

AGEs and sRAGE Variations at Different Timepoints in Patients with Chronic Kidney Disease
by: Paolo Molinari, et al.
Published: (2021-12-01)

The Ser82 RAGE Variant Affects Lung Function and Serum RAGE in Smokers and sRAGE Production In Vitro.
by: Suzanne Miller, et al.
Published: (2016-01-01)

Methylglyoxal-Derived Nucleoside Adducts Drive Vascular Dysfunction in a RAGE-Dependent Manner
by: Seigmund Wai Tsuen Lai, et al.
Published: (2024-01-01)

Increased glycated albumin and decreased esRAGE levels in serum are related to negative coronary artery remodeling in patients with type 2 diabetes: an Intravascular ultrasound study
by: Run Du, et al.
Published: (2018-11-01)

Advanced Glycation End-Products (AGEs) and Their Soluble Receptor (sRAGE) in Women Suffering from Systemic Lupus Erythematosus (SLE)
by: Agnieszka Nowak, et al.
Published: (2021-12-01)

Reduced sRAGE Production and ADAM10 Gene Expression in Peripheral Blood Samples of Diabetic Nephropathy Patients
by: Claire Gabriella Dias, et al.
Published: (2022-01-01)

Effects of acute aerobic exercise on circulating sTLR and sRAGE profiles in normal‐ and abnormal‐glucose‐tolerant individuals
by: Ryan K. Perkins, et al.
Published: (2023-11-01)

Serum sRAGE, sRANKL and osteoprotegerin in subgroups of rheumatoid arthritis patients: biomarkers associated with iron and disease status
by: Ginka Delcheva, et al.
Published: (2023-03-01)

Oleic Acid Status Positively Correlates with the Soluble Receptor for Advanced Glycation End-Products (sRAGE) in Healthy Adults Who Are Homozygous for G Allele of RAGE G82S Polymorphism
by: Permal Deo, et al.
Published: (2023-06-01)

Stingless bee propolis, metformin, and their combination alleviate diabetic cardiomyopathy
by: Oon Zhi Lim, et al.
Published: (2022-07-01)

The Anti-AGEing and RAGEing Potential of Isothiocyanates
by: Bradley A. Krisanits, et al.
Published: (2024-12-01)

The TGF-β/MMP9/RAGE axis induces sRAGE secretion by neutrophils and promotes oral carcinogenesis
by: Xiaolin Chen, et al.
Published: (2024-07-01)

sRAGE levels are decreased in plasma and sputum of COPD secondary to biomass-burning smoke and tobacco smoking: Differences according to the rs3134940 AGER variant
by: Ingrid Fricke-Galindo, et al.
Published: (2024-04-01)

sRAGE no choque séptico: um potencial biomarcador de mortalidade
by: Mike Yoshio Hamasaki, et al.
Published: (2014-12-01)

Fructose-mediated AGE-RAGE axis: approaches for mild modulation
by: Halyna Semchyshyn
Published: (2024-12-01)

Metabolic Derangements Contribute to Reduced sRAGE Isoforms in Subjects with Alzheimer’s Disease
by: Kelly N. Z. Fuller, et al.
Published: (2018-01-01)

sRAGE and early signs of cardiac target organ damage in mild hypertensives
by: Andrea Maria Maresca, et al.
Published: (2019-02-01)

The AGE-RAGE Axis: Implications for Age-Associated Arterial Diseases
by: Laura M. Senatus, et al.
Published: (2017-12-01)

Soluble receptor for advanced glycation end product (sRAGE) levels in adolescents with obesity, insulin resistance and metabolic syndrome: A case-control study and the review of the literature
by: Pembe Soylu Ustkoyuncu, et al.
Published: (2025-09-01)

RAGE Knockout Mitigates Diet-Induced Obesity and Metabolic Disruption
by: Isabelle L. Palmer, et al.
Published: (2025-08-01)

Endogenous Secretory RAGE as a Novel Biomarker for Metabolic Syndrome and Cardiovascular Diseases
by: Hidenori Koyama, et al.
Published: (2007-01-01)

Association between Preoperative Plasma sRAGE Levels and Recovery from Cardiac Surgery
by: Benedict C. Creagh-Brown, et al.
Published: (2013-01-01)

Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD
by: Katherine A. Pratte, et al.
Published: (2021-04-01)

Antiglycative Activity and RAGE Expression in Rett Syndrome
by: Valeria Cordone, et al.
Published: (2019-02-01)

Targeting the AGEs-RAGE axis: pathogenic mechanisms and therapeutic interventions in diabetic wound healing
by: Haohui Lin, et al.
Published: (2025-09-01)

The RAGE Axis: A Relevant Inflammatory Hub in Human Diseases
by: Armando Rojas, et al.
Published: (2024-03-01)

sRAGE as a Prognostic Biomarker in ARDS: Insights from a Clinical Cohort Study
by: Ana Andrijevic, et al.
Published: (2025-01-01)

The Immune Tolerance Role of the HMGB1-RAGE Axis
by: Haruki Watanabe, et al.
Published: (2021-03-01)

The contribution of adiponectin to diabetic retinopathy progression: Association with the AGEs-RAGE pathway
by: Min Fu, et al.
Published: (2024-09-01)

RAGE is a critical factor of sex-based differences in age-induced kidney damage
by: Seerat Bajwa, et al.
Published: (2023-03-01)